Han Kun authors the China chapter of Chambers Life Sciences Global Practice Guide (2022)
April, 2022 - Beijing, Mainland China
The world's leading legal directory Chambers and Partners recently published its Life Sciences Global Practice Guide (2022) (the "Guide"). Han Kun contributed the Trends and Developments section of the Guide's China chapter. The contributors include Min Zhu, Yaling (Michelle) Gon, Yang (Aaron) Gu, Lu Chai, Dr. Ying Li, and Shiye Yuan.
The launch of Chambers' Life Sciences Global Practice Guide indicates the importance of life sciences during the COVID-19 pandemic. There have been profound changes in the Chinese legal, regulatory, and market landscapes during 2021. The Guide's China chapter covers major changes in venture capital/private equity financing, merger and acquisition, and license-in/out deals in the life sciences industry; drug and medical device regulatory developments; compliance practices in respect of commercial bribery, data compliance, and ESG (environmental, social and governance); and new Chinese intellectual property regulations and tax incentives for the life sciences industry.
Han Kun has a dedicated life sciences and healthcare team and has been consistently ranked as a leading law firm in the life sciences and healthcare sector by authoritative legal directories, including Chambers and Partners, The Legal 500, Asialaw Profiles, and China Business Law Journal. The firm is committed to providing clients in the life sciences and healthcare sector with comprehensive legal services, including private equity and venture capital, mergers and acquisitions, onshore and offshore capital markets, pharmaceutical license in/out, and asset sale/purchase transactions, intellectual property, compliance and regulatory, data protection, and dispute resolution.
